Indian airline, SpiceJet, informed the bourses on Friday that the company has been designated as Indian scheduled carrier to operate on agreed services between India and the UK in accordance with the air services agreement between the Government of India and the Government of the United Kingdom

IHS Markit has released a report, which states that the growth of India’s gross domestic product (GDP) is likely to recover in the second half of 2020.  IHS is of the view that if the impact of the COVID-19 pandemic recedes, India would project a GDP growth of 6.7 per cent in FY22E

BEML Limited informed the bourses on Tuesday that it has secured an order worth Rs 557 crore.  The acquisition wing of Ministry of Defence (MoD) has signed a contract with BEML for the procurement of 1,512 mine plough (MP) for tank T-90 S/SK

Elgi Equipments on Tuesday informed the bourses that it has signed a memorandum of understanding (MoU) with Government of Tamil Nadu on July 20, 2020

India Ratings and Research (Ind-Ra) in its latest report stated that the government's fiscal deficit is estimated to touch 7.6 per cent in FY21, more than double the Budget Estimate (BE), as the nation spends extra to lessen the impact of the COVID-19 pandemic while facing a shortfall in incomes

The domestic rating agency ICRA in its latest report has revised its forecast for the contraction in India’s gross domestic product (GDP) growth to 9.5 per cent in the current fiscal (FY21) from the earlier assessment of 5 per cent

In its latest report, CRISIL Research observes that Indian Airlines may face massive revenue loss due to the ongoing Coronavirus pandemic

India Ratings & Research (Ind-Ra) in its latest report has pointed out that the private sector’s capital expenditure is set to contract by 20-26 per cent in the ongoing financial year, owing to COVID-19 pandemic-led business disruptions

The rating agency Fitch in its latest report said that a near-term recovery for India's non-banking financial institutions is not probable, as the sector continues to wrestle with the fallout of Coronavirus pandemic

Unichem Laboratories informed the bourses on Friday that it has received abbreviated new drug application (ANDA) approval for its Baclofen tablets, USP, 10 mg and 20 mg from United States Food and Drug Administration (USFDA) to market a generic version of Lioresal  (Baclofen)